JPMorgan Equity Premium Income ETF against Schwab U.S. Dividend Equity ETF: fees, dividend yield, size, holdings and price performance.
Prices as of 2026-11-20 21:00 UTC · updates daily
SCHD charges 0.06% a year and JEPI charges 0.35%: on $10,000 that is $6 against $35 a year. JEPI yields 7.93% and SCHD yields 2.95%. None of the top 10 holdings of JEPI and SCHD are the same. Over the last year the price of JEPI is -2.9% and SCHD is +27.5%, dividends not included.
| JEPI | SCHD | |
|---|---|---|
| Expense ratio | 0.35% | 0.06% |
| Dividend yield | 7.93% | 2.95% |
| Assets | $46.2 billion | $121.1 billion |
| Launched | May 20, 2020 | Oct 20, 2011 |
| 3-year return, a year | +9.8% | +18.4% |
| 5-year return, a year | +7.1% | +9.9% |
| Category | Derivative Income | Large Value |
| Issuer | JPMorgan | Schwab ETFs |
Fund facts: Yahoo Finance, read Nov 19, 2026. Yield is the trailing 12 months; multi-year returns are annualised.
None of the top 10 holdings of JEPI and SCHD are the same.
| # | JEPI top holdings | SCHD top holdings |
|---|---|---|
| 1 | Mastercard Inc Class A 2.0% | Texas Instruments Inc 4.6% |
| 2 | Apple Inc 1.9% | ConocoPhillips 4.3% |
| 3 | Microsoft Corp 1.9% | Chevron Corp 4.3% |
| 4 | Visa Inc Class A 1.9% | Procter & Gamble Co 4.2% |
| 5 | NextEra Energy Inc 1.8% | Coca-Cola Co 4.1% |
| 6 | Johnson & Johnson 1.8% | Amgen Inc 4.1% |
| 7 | EOG Resources Inc 1.8% | The Home Depot Inc 4.0% |
| 8 | 3M Co 1.8% | UnitedHealth Group Inc 4.0% |
| 9 | JPMorgan Prime Money Market IM 1.8% | Merck & Co Inc 3.8% |
| 10 | AbbVie Inc 1.8% | PepsiCo Inc 3.8% |
Largest sectors — JEPI: Technology 18%, Health care 14%, Industrials 14%, Financials 12%, Consumer cyclical 11%. SCHD: Consumer defensive 20%, Health care 19%, Energy 16%, Technology 16%, Financials 9%.
SCHD leads 7 of the 7 windows we measure — over 1 month JEPI is -5.4% and SCHD -2.1%; over year to date JEPI is -5.2% and SCHD +23.7%. The JEPI/SCHD price ratio stands at 1.5984, below its 50-day average of 1.6565, and below the 200-day average of 1.7441. A ratio above its own average means JEPI is gaining on SCHD; on this reading the recent edge belongs to SCHD.
Compare JEPI and SCHD: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| JEPI | SCHD | |
|---|---|---|
| Price | $54.25 | $33.94 |
| 1 day | -2.3% | -0.8%lead |
| 5 days | -6.4% | -6.0%lead |
| 1 month | -5.4% | -2.1%lead |
| 6 months | -3.4% | +5.7%lead |
| Year to date | -5.2% | +23.7%lead |
| 1 year | -2.9% | +27.5%lead |
| 2 years | -8.8% | +18.2%lead |
| 52-week position | 4% of range | 74% of range |
| 52-week range | $54.02–$59.90 | $26.94–$36.38 |
| vs 50-day average | below $56.84 | below $34.34 |
| vs 200-day average | below $57.06 | above $32.79 |
| RSI (14) | 29 | 37 |
| Next earnings | — | — |
JEPI trades at $54.25, below its 50-day average of $56.84, and below the 200-day at $57.06. It sits at 4% of its 52-week range ($54.02–$59.90); 14-day RSI is 29, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $55.71 (2.7% away) and the first support below is $50.00 (7.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
SCHD trades at $33.94, below its 50-day average of $34.34, and above the 200-day at $32.79. It sits at 74% of its 52-week range ($26.94–$36.38); 14-day RSI is 37, in neutral territory; an average session moves it about 1.7%. For levels, the first level overhead is $34.34 (1.2% away) and the first support below is $32.79 (3.4% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
Both move about the same amount day to day (1.7% and 1.7% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: JEPI clearing $55.71 or losing $50.00; SCHD clearing $34.34 or losing $32.79. Until one of them gives way, the relative reading above stands.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.